BRINTELLIX

H. Lundbeck A/S

Application Filed: 2020-03-23
Trademark Application Details
Trademark Logo BRINTELLIX

Mark For: BRINTELLIX® trademark registration is intended to cover the categories of vaccines; pharmaceutical preparations for treatment and prevention of central nervous system diseases and disorders; pharmaceutical preparations acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations for the treatment and prevention of dementia, Alzheimer's disease and disorder, dizziness, seizures, strokes, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety disorder, apathy disorder, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, balance disorders, movement disorders and diseases, dyskinesia, motor disorder, tremors, schizophrenia, bipolar disorder and disease, mania, Attention Deficit Hyperactivity Disorder, Post Traumatic Stress Disorder, agitated major depressive disorder, intermittent explosive disorder, autism, melancholic depression, tourette's syndrome, progressive supranuclear palsy (PSP), restless leg syndrome, akathisia, chronic fatigue syndrome, somnolence, nausea, cancer, headache, migraine, pain, alcoholism and chemical dependency; diagnostic agents, preparations and substances for medical purposes. [all]

Status

2020-10-25 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88844656
Registration Number6255044
Mark Literal ElementsBRINTELLIX
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationPUBLICATION AND ISSUE SECTION 2020-10-08
Basis44(e)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseNo
Filed ITUNo
44D FiledNo
44E CurrentYes
66A CurrentNo
Current BasisNo
No BasisNo
Domestic RepresentativeClaudia A. Smith
Attorney NameClaudia A. Smith
Attorney Docket NumberLUNBECKBRINT

Timeline

2011-11-17Trademark Registered
2020-03-23Application Filed
2020-03-26Location: NEW APPLICATION PROCESSING
2020-03-26Status: Live/Pending
2020-03-26Transaction Date
2020-10-08Location: PUBLICATION AND ISSUE SECTION
2020-10-08Status: Review prior to publication completed.
2020-11-10Published
2021-01-26Trademark Registered

Trademark Parties (Applicants & Owners)

Party: H. Lundbeck A/S
AddressOttiliavej 9 Valby DENMARK 2500
Legal Entity TypeAktieselskab (a/s)
Legal Entity StateDENMARK

Attorney of Record

CLAUDIA A. SMITH
WHITE & CASE LLP
1221 AVENUE OF THE AMERICAS
TRADEMARK DEPARTMENT
NEW YORK, NY 10020

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Vaccines; pharmaceutical preparations for treatment and prevention of central nervous system diseases and disorders; pharmaceutical preparations acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations for the treatment and prevention of dementia, Alzheimer's disease and disorder, dizziness, seizures, strokes, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety disorder, apathy disorder, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, balance disorders, movement disorders and diseases, dyskinesia, motor disorder, tremors, schizophrenia, bipolar disorder and disease, mania, Attention Deficit Hyperactivity Disorder, Post Traumatic Stress Disorder, agitated major depressive disorder, intermittent explosive disorder, autism, melancholic depression, tourette's syndrome, progressive supranuclear palsy (PSP), restless leg syndrome, akathisia, chronic fatigue syndrome, somnolence, nausea, cancer, headache, migraine, pain, alcoholism and chemical dependency; diagnostic agents, preparations and substances for medical purposes

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Vaccines, pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, pharmaceutical preparations and substances acting on the central nervous system, central nervous system stimulants, pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases, pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, dyskinesia, poor or absent motor functions, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, headache, migraine, pain, alcoholism and chemical dependency, diagnostic agents, reagents, preparations and substances for medical purposes
GS0051Vaccines; pharmaceutical preparations for treatment and prevention of central nervous system diseases and disorders; pharmaceutical preparations acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations for the treatment and prevention of dementia, Alzheimer's disease and disorder, dizziness, seizures, strokes, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety disorder, apathy disorder, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, balance disorders, movement disorders and diseases, dyskinesia, motor disorder, tremors, schizophrenia, bipolar disorder and disease, mania, Attention Deficit Hyperactivity Disorder, Post Traumatic Stress Disorder, agitated major depressive disorder, intermittent explosive disorder, autism, melancholic depression, tourette's syndrome, progressive supranuclear palsy (PSP), restless leg syndrome, akathisia, chronic fatigue syndrome, somnolence, nausea, cancer, headache, migraine, pain, alcoholism and chemical dependency; diagnostic agents, preparations and substances for medical purposes

Trademark Filing History

DescriptionDateProceeding Number
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2020-10-21
APPROVED FOR PUB - PRINCIPAL REGISTER2020-10-08
TEAS/EMAIL CORRESPONDENCE ENTERED2020-10-0788889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2020-10-06
CORRESPONDENCE RECEIVED IN LAW OFFICE2020-10-0688889
NOTIFICATION OF NON-FINAL ACTION E-MAILED2020-06-136325
NON-FINAL ACTION WRITTEN2020-06-1393936
NON-FINAL ACTION E-MAILED2020-06-136325
ASSIGNED TO EXAMINER2020-06-1393936
ASSIGNED TO LIE2020-05-1273296
APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED2020-05-1273296
ASSIGNED TO LIE2020-05-0474221
TEAS VOLUNTARY AMENDMENT RECEIVED2020-04-30
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2020-04-01
NEW APPLICATION ENTERED IN TRAM2020-03-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed